1. Home
  2. VIAV vs IOVA Comparison

VIAV vs IOVA Comparison

Compare VIAV & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIAV
  • IOVA
  • Stock Information
  • Founded
  • VIAV 1923
  • IOVA 2007
  • Country
  • VIAV United States
  • IOVA United States
  • Employees
  • VIAV N/A
  • IOVA N/A
  • Industry
  • VIAV Semiconductors
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VIAV Technology
  • IOVA Health Care
  • Exchange
  • VIAV Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • VIAV 2.2B
  • IOVA 2.6B
  • IPO Year
  • VIAV 1993
  • IOVA N/A
  • Fundamental
  • Price
  • VIAV $10.20
  • IOVA $7.38
  • Analyst Decision
  • VIAV Hold
  • IOVA Strong Buy
  • Analyst Count
  • VIAV 9
  • IOVA 9
  • Target Price
  • VIAV $11.16
  • IOVA $23.33
  • AVG Volume (30 Days)
  • VIAV 1.7M
  • IOVA 5.8M
  • Earning Date
  • VIAV 01-30-2025
  • IOVA 11-07-2024
  • Dividend Yield
  • VIAV N/A
  • IOVA N/A
  • EPS Growth
  • VIAV N/A
  • IOVA N/A
  • EPS
  • VIAV N/A
  • IOVA N/A
  • Revenue
  • VIAV $990,700,000.00
  • IOVA $90,858,000.00
  • Revenue This Year
  • VIAV $4.76
  • IOVA $13,758.71
  • Revenue Next Year
  • VIAV $6.97
  • IOVA $171.64
  • P/E Ratio
  • VIAV N/A
  • IOVA N/A
  • Revenue Growth
  • VIAV N/A
  • IOVA 12751.20
  • 52 Week Low
  • VIAV $6.60
  • IOVA $6.70
  • 52 Week High
  • VIAV $11.49
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • VIAV 48.12
  • IOVA 32.93
  • Support Level
  • VIAV $10.03
  • IOVA $7.06
  • Resistance Level
  • VIAV $11.49
  • IOVA $7.86
  • Average True Range (ATR)
  • VIAV 0.39
  • IOVA 0.41
  • MACD
  • VIAV -0.07
  • IOVA -0.10
  • Stochastic Oscillator
  • VIAV 12.84
  • IOVA 14.29

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of revenue from the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: